Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812186 · ClinicalTrials.gov registry record · Phase 4
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
NCT02812186 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 79 participants.
The verdict
NCT02812186, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a two period cross-over study randomizing patients undergoing laparoscopic surgery into 2 different groups: group 1 in which patients receive "deep neuromuscular blockade" in the beginning portion of their laparoscopic surgery followed by a period of "moderate blockade" and, group 2 in which patients receive "moderate neuromuscular blockade" in the beginning portion of their laparoscopic surgery followed by a period of "deep blockade". The deep neuromuscular block is defined as post tetanic count of 1 to 2 and the moderate neuromuscular block is defined as 1-2 twitches. In all patients, sugammadex is used to reverse the block at the end of surgery in order to obtain optimal extubating conditions.
Interventions
- DRUG Rocuronium
- PROCEDURE Deep to Moderate NMB
- PROCEDURE Moderate to Deep NMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-12-27 |
| Est. Completion | 2019-02-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02812186
The ClinicalTrials.gov registry entry for NCT02812186 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rocuronium is the first listed.
NCT02812186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02812186 about?
NCT02812186 is a clinical study titled "Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery". This is a two period cross-over study randomizing patients undergoing laparoscopic surgery into 2 different groups: group 1 in which patients receive "deep neuromuscular blockade" in the beginning portion of their laparoscopic surgery followed by a period of "moderate blockade" and, group 2 in which...
What is the current status of trial NCT02812186?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2016-12-27. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT02812186?
The interventions under investigation include: Rocuronium (DRUG), Deep to Moderate NMB (PROCEDURE), Moderate to Deep NMB (PROCEDURE).
Who is sponsoring clinical trial NCT02812186?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.